Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

NCT02161731 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Evacetrapib
DRUG: Warfarin

Sponsor

Eli Lilly and Company